Livforsakringsbolaget Skandia Omsesidigt grew its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 106.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 82,512 shares of the healthcare conglomerate’s stock after acquiring an additional 42,450 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in UnitedHealth Group were worth $25,741,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Bayforest Capital Ltd lifted its position in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 50 shares in the last quarter. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $42,000. Copia Wealth Management acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $42,000. Finally, O Brien Wealth Partners LLC raised its holdings in shares of UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after buying an additional 37 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on UNH. Sanford C. Bernstein increased their target price on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a report on Friday, September 5th. Morgan Stanley raised their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday. Bank of America raised their price target on UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a report on Monday, August 18th. TD Securities reaffirmed a “hold” rating and set a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Finally, UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $358.95.
UnitedHealth Group Trading Down 1.3%
NYSE UNH opened at $348.05 on Tuesday. The firm has a market cap of $315.22 billion, a P/E ratio of 15.08, a P/E/G ratio of 2.30 and a beta of 0.44. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock’s 50-day moving average is $292.87 and its 200-day moving average is $367.43. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period in the prior year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- Top Biotech Stocks: Exploring Innovation Opportunities
- Reddit Hits Record Highs: Why Wall Street Is Taking Notice
- What is the Nasdaq? Complete Overview with History
- After a Strong Wall Street Debut, Klarna’s Real Work Begins
- Consumer Discretionary Stocks Explained
- 3 Dividend Growers That Fly Under the Radar
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.